Arkolith/Insider Trading/APGE/Form 4

Henderson Michael Thomas

Chief Executive Officer, DirectorApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Jan 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 14, 2026Sell(S)8K$79.82$677K1.2M
Jan 14, 2026Sell(S)2K$81.00$192K1.2M
Jan 14, 2026Sell(S)2K$82.41$153K1.2M
Jan 14, 2026Sell(S)470$83.79$39K1.2M
Jan 14, 2026Sell(S)1K$78.64$113K1.2M
Jan 14, 2026Sell(S)5K$83.16$448K1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-004659) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML